BR0310033A - Inibidores da transcriptase reversa de não-nucleosìdeo - Google Patents

Inibidores da transcriptase reversa de não-nucleosìdeo

Info

Publication number
BR0310033A
BR0310033A BR0310033-2A BR0310033A BR0310033A BR 0310033 A BR0310033 A BR 0310033A BR 0310033 A BR0310033 A BR 0310033A BR 0310033 A BR0310033 A BR 0310033A
Authority
BR
Brazil
Prior art keywords
alkyl
reverse transcriptase
group
transcriptase inhibitors
aryl
Prior art date
Application number
BR0310033-2A
Other languages
English (en)
Inventor
Bruno Simoneau
Eric Malenfant
Julie Naud
Serge Landry
Jeffrey O'meara
Bounkham Thavonekham
Christiane Yoakim
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR0310033A publication Critical patent/BR0310033A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"INIBIDORES DA TRANSCRIPTASE REVERSA DE NãO-NUCLEOSìDEO". A presente invenção refere-se a compostos representados pela fórmula (I) em que R^ 2^ é selecionado do grupo consistindo em H, (C~ 1-4~) alquila, halo, haloalquila, OH, (C~ 1-6~) alcóxi, NH(C~ 1-4~ alquila) ou N(C~ 1-4~ alquila)~ 2~; R^ 4^ é H ou Me; R^ 5^ é H ou Me; R^ 11^ é H, (C~ 1-4~) alquila, (C~ 3-4~) cicloalquila e (C~ 1-4~) alquil-(C~ 3-4~) cicloalquila; A é uma cadeia de conexão de (C~ 1-3~) alquila; B é O ou S; n é O ou 1; em que quando n for 0: o Anel C é arila de 6 ou 10 membros ou heterociclo de 5 ou 6 membros tendo de 1 a 4 heteroátomos selecionados do grupo consistindo em 0, N, e S, dita arila e dito heterociclo sendo opcionalmente substituídos; e E é CONR^ 12^R^ 13^; CONHNR^ 14^R^ 15^; NR^ 16^COR^ 17^; NR^ 18~S0~ 2~(C~ 1-6~) alquila; SO~ 2~NR^ 19^R^ 20^; OU SO~ 2~R^ 21^; ou quando n for 1: o Anel C é como definido acima e E é uma ligação simples ou um grupo de conexão; e o Anel D é arila de 6 ou 10 membros ou heterociclo de 5 ou 6 membros tendo de 1 a 4 heteroátomos selecionados do grupo consistindo em O, N, e S, a dita arila e o dito heterociclo sendo opcionalmente substituídos com de 1 a 5 substituintes; ou um sal ou uma pró-droga dos mesmos são fornecidos como inibidores da transcriptase reversa do HIV.
BR0310033-2A 2002-05-16 2003-05-14 Inibidores da transcriptase reversa de não-nucleosìdeo BR0310033A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38088602P 2002-05-16 2002-05-16
PCT/CA2003/000718 WO2003097644A2 (en) 2002-05-16 2003-05-14 Non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
BR0310033A true BR0310033A (pt) 2005-02-15

Family

ID=29550032

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0310033-2A BR0310033A (pt) 2002-05-16 2003-05-14 Inibidores da transcriptase reversa de não-nucleosìdeo

Country Status (29)

Country Link
US (1) US6806265B2 (pt)
EP (1) EP1506195B1 (pt)
JP (1) JP4230448B2 (pt)
KR (1) KR20050008716A (pt)
CN (1) CN1318421C (pt)
AR (1) AR040027A1 (pt)
AT (1) ATE412653T1 (pt)
AU (1) AU2003229186A1 (pt)
BR (1) BR0310033A (pt)
CA (1) CA2485916C (pt)
DE (1) DE60324418D1 (pt)
EA (1) EA009178B1 (pt)
EC (1) ECSP045432A (pt)
ES (1) ES2315492T3 (pt)
HK (1) HK1080849A1 (pt)
HR (1) HRP20041065A2 (pt)
IL (1) IL163753A0 (pt)
MX (1) MXPA04010409A (pt)
MY (1) MY134646A (pt)
NO (1) NO20044104L (pt)
NZ (1) NZ536736A (pt)
PE (1) PE20040365A1 (pt)
PL (1) PL371663A1 (pt)
RS (1) RS98004A (pt)
TW (1) TW200404071A (pt)
UA (1) UA79285C2 (pt)
UY (1) UY27809A1 (pt)
WO (1) WO2003097644A2 (pt)
ZA (1) ZA200406912B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1610797A1 (en) * 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of nevirapine and a further antiretroviral compound
KR101415503B1 (ko) 2003-07-17 2014-07-04 플렉시콘, 인코퍼레이티드 Ppar 활성 화합물
US7348338B2 (en) 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
DE102004051277A1 (de) * 2004-10-21 2006-04-27 Merck Patent Gmbh Heterocyclische Carbonylverbindungen
JP2008521829A (ja) * 2004-11-30 2008-06-26 プレキシコン,インコーポレーテッド Ppar活性化合物
US20080234349A1 (en) * 2005-09-07 2008-09-25 Jack Lin PPAR active compounds
JP2009507846A (ja) * 2005-09-07 2009-02-26 プレキシコン,インコーポレーテッド Ppar活性化合物
CN101304992A (zh) * 2005-09-07 2008-11-12 普莱希科公司 用作ppar调节剂的1,3-二取代吲哚衍生物
WO2008051197A2 (en) 2005-09-20 2008-05-02 Mayo Foundation For Medical Education And Research Small-molecule botulinum toxin inhibitors
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
CN107428747A (zh) 2014-11-25 2017-12-01 拜耳制药股份公司 取代的吡啶并苯并二氮杂*酮衍生物及其用途
MA49623A (fr) 2017-07-21 2021-03-17 Antabio Sas Composés chimiques
WO2019226213A2 (en) 2018-03-08 2019-11-28 Incyte Corporation AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5705499A (en) * 1995-10-06 1998-01-06 Boehringer Ingelheim Pharmaceuticals, Inc. 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection
TWI270547B (en) 2000-06-16 2007-01-11 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
WO2003097644A3 (en) 2004-02-05
JP4230448B2 (ja) 2009-02-25
RS98004A (en) 2006-12-15
CN1318421C (zh) 2007-05-30
ES2315492T3 (es) 2009-04-01
ECSP045432A (es) 2005-01-03
AR040027A1 (es) 2005-03-09
MXPA04010409A (es) 2005-02-17
EA009178B1 (ru) 2007-12-28
JP2005526851A (ja) 2005-09-08
HK1080849A1 (en) 2006-05-04
UY27809A1 (es) 2003-12-31
KR20050008716A (ko) 2005-01-21
UA79285C2 (en) 2007-06-11
MY134646A (en) 2007-12-31
ATE412653T1 (de) 2008-11-15
US6806265B2 (en) 2004-10-19
NZ536736A (en) 2006-11-30
CN1653066A (zh) 2005-08-10
EP1506195A2 (en) 2005-02-16
EP1506195B1 (en) 2008-10-29
AU2003229186A1 (en) 2003-12-02
NO20044104L (no) 2004-12-01
TW200404071A (en) 2004-03-16
DE60324418D1 (de) 2008-12-11
WO2003097644A2 (en) 2003-11-27
PE20040365A1 (es) 2004-07-22
US20040006071A1 (en) 2004-01-08
HRP20041065A2 (en) 2005-04-30
IL163753A0 (en) 2005-12-18
PL371663A1 (en) 2005-06-27
ZA200406912B (en) 2006-06-28
CA2485916A1 (en) 2003-11-27
CA2485916C (en) 2009-12-08
EA200401482A1 (ru) 2005-06-30

Similar Documents

Publication Publication Date Title
BR0310033A (pt) Inibidores da transcriptase reversa de não-nucleosìdeo
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
BR0208985A (pt) Derivados de 2-iminopirrolidina
BRPI0514644A (pt) composto fosforamidita, composto ácido ribonucléico, e método para produzir oligo-rna
BRPI0509258A8 (pt) composto de 8-oxoadenina 9-substituída
CO6140059A2 (es) Derivados de imidazol-pirimidina para el tratamiento de enfermedades relacionadas con la glicogeno sintasa quinasa (gsk3)
BR0108303A (pt) Derivados do 1h-imidazopiridina
DE50311967D1 (de) 3-heteroarylsubstituierte 5-methyloxymethyl-isoxazoline als herbizide
BR0114436A (pt) Composto com anel de cinco elementos contendo nitrogênio alifático
DE602005023343D1 (de) Pyrimidinderivate als gpcr-agonisten
PE20020476A1 (es) Derivados de glucopiranosiloxibencilbenceno y composiciones farmaceuticas que comprenden los mismos
EP1679309A4 (en) ANTISTRESS MEDICAMENT AND ITS MEDICAL USE
CO5690585A2 (es) Uso de inhibidores de la ikb-quinasa para el tratamiento del dolor
BR9810555A (pt) Derivados epotilona
NO20052887L (no) Pyridazinonderivater som GSK-3Beta inhibitorer.
BR0312129A (pt) Derivados de espiroindolinapiperidina
NO20051328L (no) Kalsiumreseptormodulerende forbindelse og anvendelse derav
DK1008592T3 (da) Cykliske amidderivater, som inhiberer cathepsin K
ATE503746T1 (de) Neue imidazolidinderivate
ECSP088805A (es) 2-(piridin-2-il)-pirimidinas como fungicidas
BRPI0406721A (pt) Compostos condensados de furano
BRPI0406500A (pt) processo farmacêutico e compostos preparados pelo mesmo
BR0309558A (pt) Derivados de quinazolina e medicamentos
DK1970372T3 (da) Salte af 9-oxoacridin-10-eddikesyre med 1-alkylamino-1-deoxy-polyoler
PE20040750A1 (es) Derivados de n-(1-acetilpiperidin-4-il)-4-benzidril-2-isopropilpiperazin-1-carboxamida como inhibidores de 17beta-hidroxiesteroide deshidrogenasa de tipo 3

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010.